You are in a distributor managed country, to make orders please contact your local distributor
Contact Distributor
×
Learn more
Webcast featuring eSpOT-ON
Explore More
eSpOT-ON Nuclease Protein Available Now
Explore More
Order eSpOT-ON Nuclease mRNA Now
Cart
Account
Your Orders
Sign In
My Cart
Products
CRISPR GENE EDITING
Research gRNAs
→
gRNA Controls
→
CRISPR GENE EDITORS
→
eSpOT-ON Protein
→
eSpOT-ON mRNA
→
AccuBase™ Base Editor
→
hfCas12Max Nuclease
→
Research SpCas9
→
cGMP MANUFACTURING
GMP gRNA
→
GMP CRISPR Editors
→
Regulatory Expertise
→
MOLECULAR Dx
PCR & RT Enzymes & Products
→
IVT Enzymes
→
Isothermal Amplification
→
Nucleic Acid Preparation & Processing
→
Custom Manufacturing
→
Solutions
CRISPR GENE EDITING
Explore CRISPR Continuum
→
CRISPR Clinical Solutions
→
CRISPR Nucleases
→
Regulatory Expertise
→
MOLECULAR Dx
Revolutionize Molecular and Clinical Diagnostics
→
Essential IVT Enzymes
→
DESIGN & ANALYSIS
Explore CRISPR Design Tools
→
ICE CRISPR Analysis Tool
→
Learn
CRISPR GENE EDITING
What Is CRISPR
→
How To Use CRISPR Guide
→
CRISPR Methods
→
Other Genome Editing Tools And Applications
→
Base Editing
→
CAR-T Cell Therapy
→
CRISPR in iPS Cells
→
MOLECULAR Dx
RT-RPA Guide
→
RPA Guide
→
RESOURCE LIBRARY
Protocols
→
Application Notes
→
Case Studies
→
Videos
→
eBooks
→
Publications
→
FROM THE BENCH
Company
About
→
Newsroom
→
Careers
→
Partner With Us
→
Testimonials
→
Support
Help
→
Protocols
→
Contact
→
Order
Research sgRNA
→
hfCas12Max Nuclease
→
SpCas9 Nuclease
→
gRNA Controls
→
Your Account
Cart
→
Account
→
Edit Credit
→
Your Orders
→
Sign In
→
Sign Out
→
Contact Sales
Newsroom
Stay Connected with Our Latest News and Media Assets
Contact Us
Download Synthego Logo
Showing 12 of 106
Synthego Launches High-Performance Molecular Reagents for Clinical and Molecular Diagnostics
Nov 10, 2025
Synthego Announces Successful Close of Acquisition by Perceptive Advisors
Jul 21, 2025
Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July
Jun 26, 2025
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
Jun 12, 2025
Synthego Introduces GMP SpCas9 to Accelerate Gene Editing for Therapeutic Advancement
May 12, 2025
Synthego Initiates Strategic Financial Restructuring to Facilitate Sale, Reduce Debt, Strengthen Balance Sheet
May 5, 2025
Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
Apr 8, 2025
AstraZeneca, Synthego ink gene editing enzyme licensing deal
Jan 13, 2025
Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme eSpOT-ON
Jan 13, 2025
Synthego Launches High-Value IVT Enzymes for Advanced RNA Therapeutics
Nov 4, 2024
Synthego Launches hfCas12Max High-Fidelity CRISPR Enzyme for Therapeutic Development
Jun 3, 2024
EditCo Bio and Telegraph Hill Partners Acquire Synthego’s Engineered Cell Solutions Business to Enable Cellular Research
Mar 27, 2024
Cart
Account
Your Orders
Sign In